NCT02612259View on ClinicalTrials.gov

A Phase II, Randomized, Double-blind, Placebo-controlled, in Parallel Groups Clinical Trial to Assess the Safety and Efficacy of Dietary Supplementation With Tryptophan to Achieve Weight Loss, and Its Neuropsychological Effects in Adolescents With Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

TRYPTOPHAN

at the dose of 3,5 m/kg/ day divided in two capsules

OTHER

PLACEBO

at the dose of 3,5 m/kg/ day divided in two capsules

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Fundació Sant Joan de Déu

OTHER

NCT02612259 - A Phase II, Randomized, Double-blind, Placebo-controlled, in Parallel Groups Clinical Trial to Assess the Safety and Efficacy of Dietary Supplementation With Tryptophan to Achieve Weight Loss, and Its Neuropsychological Effects in Adolescents With Obesity | Biotech Hunter | Biotech Hunter